2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the …
K Zeppenfeld, J Tfelt-Hansen, M De Riva… - European heart …, 2022 - academic.oup.com
4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …
European heart rhythm association (EHRA)/heart rhythm society (HRS)/Asia pacific heart rhythm society (APHRS)/latin American heart rhythm society (LAHRS) expert …
AAM Wilde, C Semsarian, MF Márquez, AS Shamloo… - Europace, 2022 - academic.oup.com
Purpose Genetic testing has advanced significantly since the publication of the 2011
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the …
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the …
[PDF][PDF] Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects
H Könemann, N Dagres, JL Merino, C Sticherling… - Europace, 2023 - academic.oup.com
Sudden cardiac death and ventricular arrhythmias are a global health issue. Recently, a
new guideline for the management of ventricular arrhythmias and prevention of sudden …
new guideline for the management of ventricular arrhythmias and prevention of sudden …
Rare variant genetics and dilated cardiomyopathy severity: the DCM precision medicine study
M Hofmeyer, GJ Haas, E Jordan, J Cao, E Kransdorf… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Dilated cardiomyopathy (DCM) can lead to advanced disease, defined
herein as necessitating a durable left ventricular assist device or a heart transplant …
herein as necessitating a durable left ventricular assist device or a heart transplant …
Association of titin variations with late-onset dilated cardiomyopathy
Importance Dilated cardiomyopathy (DCM) is frequently caused by genetic factors. Studies
identifying deleterious rare variants have predominantly focused on early-onset cases, and …
identifying deleterious rare variants have predominantly focused on early-onset cases, and …
Diagnosis and risk prediction of dilated cardiomyopathy in the era of big data and genomics
A Sammani, AF Baas, FW Asselbergs… - Journal of clinical …, 2021 - mdpi.com
Dilated cardiomyopathy (DCM) is a leading cause of heart failure and life-threatening
ventricular arrhythmias (LTVA). Work-up and risk stratification of DCM is clinically …
ventricular arrhythmias (LTVA). Work-up and risk stratification of DCM is clinically …
Automatic identification of patients with unexplained left ventricular hypertrophy in electronic health record data to improve targeted treatment and family screening
Background Unexplained Left Ventricular Hypertrophy (ULVH) may be caused by genetic
and non-genetic etiologies (eg, sarcomere variants, cardiac amyloid, or Anderson-Fabry's …
and non-genetic etiologies (eg, sarcomere variants, cardiac amyloid, or Anderson-Fabry's …
[HTML][HTML] Genetic variants in Chinese patients with sporadic dilated cardiomyopathy: a cross-sectional study
C Shen, L Xu, X Sun, A Sun, J Ge - Annals of Translational …, 2022 - ncbi.nlm.nih.gov
Background Multiple genes have been associated with familial dilated cardiomyopathy
(DCM). However, the role of genetic factors in sporadic DCM (SDCM) remains unclear …
(DCM). However, the role of genetic factors in sporadic DCM (SDCM) remains unclear …
Comparison of clinical course and outcomes between dilated and hypokinetic non-dilated cardiomyopathy
E Dziewięcka, M Winiarczyk, S Wiśniowska-Śmiałek… - Cardiology, 2023 - karger.com
Background: By definition, dilated cardiomyopathy (DCM) is characterized by enlargement
of the left ventricular (LV) cavity, and systolic dysfunction. However, in 2016 ESC introduced …
of the left ventricular (LV) cavity, and systolic dysfunction. However, in 2016 ESC introduced …
Application of next generation sequencing in cardiology: current and future precision medicine implications
E Papadopoulou, D Bouzarelou, G Tsaousis… - Frontiers in …, 2023 - frontiersin.org
Inherited cardiovascular diseases are highly heterogeneous conditions with multiple genetic
loci involved. The application of advanced molecular tools, such as Next Generation …
loci involved. The application of advanced molecular tools, such as Next Generation …